››
22 RUE MARC DONADILLE, 13013 MARSEILLE
| Type | Language | Name |
|---|---|---|
| Official name | FR | PROVEPHARM |
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Net income for the year | -€42,485,472 477% | €11,276,761 46% | €20,723,748 42% | €14,639,680 |
| Equity | €11,184,478 81% | €58,669,165 12% | €52,391,620 43% | €36,667,873 |
| Balance sheet total | €103,829,450 28% | €143,613,707 40% | €102,746,298 14% | €90,036,869 |
Revenue, ratios (solvency, debt, ROE), interactive charts and full history — available in your dashboard.
Source: RNE / INPI (filed annual accounts) · Updated on June 21, 2026
PROVEPHARM is registered in the SIRENE directory under SIREN number 500 620 489.
PROVEPHARM's registered office is located at 22 RUE MARC DONADILLE, 13013 MARSEILLE.
PROVEPHARM operates under the activity “Analyses, essais et inspections techniques” (NAF/APE code 71.20B).
Full analysis: finances, establishments, directors, history — in your dashboard.
PROVEPHARM's intra-EU VAT number, derived from its SIREN, is FR 03 500 620 489. Whether it is actually active depends on the company being liable for VAT.
PROVEPHARM has the following legal form: SAS, société par actions simplifiée (5710).
PROVEPHARM was created on September 27, 2007.
Yes, PROVEPHARM is an active company according to the SIRENE / INSEE directory.
PROVEPHARM has 3 establishments in the SIRENE directory, of which 1 active.